Honoring and appreciating the gift of donation, BioCreations Medical focuses on maximizing the potential applications of allogeneic adipose human tissue.

Extensive tissue research combined with proprietary screening and processing technologies are used to allow for preservation of intrinsic tissue properties of the tissue.

Our HCT/Ps follow FDA & all applicable guidance and requirements to meet the standards of homologous use.

In 2024, BioCreations will launch 3 new proprietary, hydrated, allogeneic adipose tissue products. High and low viscosity tissue configurations will be available to address clinical challenges in Tissue Rejuvenation, Tissue Filling and Tissue Padding procedures.